News + Filings Transactions Holdings
All 13F 13D/G Other
|
Baupost Group
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
SC 13D/A
| Baupost Group reports a 2.3% stake in Garrett Motion Inc. |
08/08/2023 |
SC 13D/A
| Baupost Group reports a 2.3% stake in Garrett Motion Inc. |
07/27/2023 |
SC 13D/A
| Baupost Group reports a 6.1% stake in Garrett Motion Inc. |
07/17/2023 |
SC 13D/A
| Baupost Group reports a 8% stake in Garrett Motion Inc. |
06/15/2023 |
SC 13D/A
| Baupost Group reports a 10% stake in Garrett Motion Inc. |
12/14/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/10/2021 |
SC 13D/A
| Baupost Group reports a 22.2% stake in ViaSat, Inc. |
09/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/04/2021 |
SC 13D/A
| Baupost Group reports a 24% stake in Translate Bio, Inc. |
05/05/2021 |
SC 13D/A
| Baupost Group reports a 22.5% stake in ViaSat, Inc. |
05/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/26/2021 |
SC 13D/A
| Baupost Group reports a 4.7% stake in Garrett Motion Inc. |
01/13/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/23/2020 |
SC 13D/A
| Baupost Group reports a 4.7% stake in Garrett Motion Inc. |
11/17/2020 |
SC 13D/A
| Baupost Group reports a 4.7% stake in Garrett Motion Inc. |
11/04/2020 |
SC 13D/A
| Baupost Group reports a 4.7% stake in Garrett Motion Inc. |
08/10/2020 |
SC 13D/A
| Baupost Group reports a 24.3% stake in Translate Bio, Inc. |
07/27/2020 |
SC 13D/A
| Baupost Group reports a 24.1% stake in ViaSat, Inc. |
05/11/2020 |
SC 13D/A
| Baupost Group reports a 27.9% stake in Translate Bio, Inc. |
06/04/2019 |
SC 13D/A
| Baupost Group reports a 0% stake in Orexigen Therapeutics, Inc. |
12/13/2018 |
SC 13D/A
| Baupost Group reports a 0% stake in Keryx Biopharmaceuticals, Inc. |
10/31/2018 |
SC 13D/A
| Baupost Group reports a 37.5% stake in Orexigen Therapeutics, Inc. |
10/26/2018 |
SC 13D/A
| Baupost Group reports a 37.5% stake in Orexigen Therapeutics, Inc. |
06/29/2018 |
SC 13D/A
| Baupost Group reports a 39.4% stake in Keryx Biopharmaceuticals, Inc. |
05/10/2018 |
SC 13D/A
| Baupost Group reports a 39.7% stake in Keryx Biopharmaceuticals, Inc. |
04/26/2018 |
SC 13D/A
| Baupost Group reports a 37.5% stake in Orexigen Therapeutics, Inc. |
07/12/2016 |
SC 13D/A
| Orexigen Therapeutics, Inc. reports a 37.5% stake in Orexigen Therapeutics, Inc. |
06/01/2016 |
SC 13D/A
| KERYX BIOPHARMACEUTICALS INC reports a 42.5% stake in Keryx Biopharmaceuticals, Inc. |
04/12/2010 |
SC 13D/A
| FACET BIOTECH CORP reports a 6% stake in Facet Biotech Corp |
03/17/2010 |
SC 13D/A
| FACET BIOTECH CORP reports a 8% stake in Facet Biotech Corp |
12/28/2009 |
SC 13D/A
| RHI Entertainment, Inc. reports a 0% stake in RHI ENTERTAINMENT, INC. |
12/16/2009 |
SC 13D/A
| FACET BIOTECH CORP reports a 14% stake in FACET BIOTECH CORP |
|
|
|